BioHealth News Archive
Accepting Applications for the 6th Annual Crab trap Competition
Registration is now open for the BioHealth Capital Region 6th Annual Crab Trap Competition. The Crab Trap this year will be held virtually in affiliation…
Read MoreBioHealth Innovation Appoints Jeff Boyle to Board of Directors
ROCKVILLE, MARYLAND, July 6, 2020 – The Board of Directors of BioHealth Innovation, Inc. (BHI) unanimously approved the appointment of Jeff Boyle as a…
Read MoreBoston University Center for Emerging Infectious Diseases Policy & Research Announces New Partnership with CONNECTED DMV · BioBuzz
We are excited to announce a partnership between CEID and CONNECTED DMV. We will be cooperating with CONNECTED DMV in their Pandemic Prevention and Biodefense…
Read MoreCoronavirus (COVID-19) Update: July 2, 2021 | FDA
The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: Today, the FDA authorized the…
Read MoreSands Capital, Accolade Partners and more funds are raising money. Here’s what’s driving it. – Washington Business Journal
In Greater Washington, we spotlight these VC firms raising new funds or adding dollars to their existing ones. {iframe}https://www.bizjournals.com/washington/news/2021/07/01/sands-capital-accolade-partners-raising-new-funds.html{/iframe}
Read MoreLife Sciences Markets Eye ‘Transformative’ New Federal Investments
Arriving in Washington in the midst of a pandemic, the Biden administration has been laser-focused on funding life sciences, announcing support for the onshoring of…
Read MoreTop 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
By the end of this week, the world should cross two small but significant milestones on the road to overcoming COVID-19—getting at least 5%…
Read MoreQiagen and Sysmex Team up on Cancer Companion Diagnostics | mddionline.com
The companion diagnostics market is on track to reach $6.8 billion by 2025 (from $3.7 billion in 2020), according to a Markets and Markets…
Read MoreMIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development
LEIDEN, The Netherlands, July 06, 2021 / B3C newswire / -- MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading…
Read MoreBioTalk with Rich Bendis welcomes Howard Carolan, CEO of CoapTech, and Neil Davis, Program Director at University of Maryland Baltimore
Howard Carolan, Co-Founder and CEO of CoapTech, Inc., and Neil Davis, Program Director of the Biomedical Entrepreneurship Graduate Certificate program at the University of…
Read MoreSeven Up-and-Coming COVID-19 Drugs
Thanks to unprecedented development speed and mostly strong safety and efficacy data, vaccines have dominated the response to COVID-19. But ending the pandemic will…
Read MoreKinexum ATTD 2021 report.pdf(Shared)- Adobe Document Cloud
This document has been redacted by Sam Collaudin, Kinexum Business Strategy Consultant, independently from any pharmaceutical and biotech companies It synthesizes selected data presented…
Read MoreMoney Moves: It’s a big investment week for Frederick companies – Technical.ly Baltimore
This week, a pair of Frederick companies raised millions in new investment, offering evidence of the Maryland city’s growing role as one of the…
Read MoreRon Daniels’ tenure as Johns Hopkins University president extended through 2029 | Hub
Johns Hopkins University's board of trustees has voted unanimously to add a new five-year term to the presidential tenure of Ron Daniels, an extension…
Read MoreVigene Biosciences closes deal to be acquired by Charles River Laboratories – Washington Business Journal
The firm helps gene therapy and vaccine companies develop and manufacture products for rare diseases. Image: Vigene Biosciences, led by CEO Zairen Sun, right,…
Read More